The original letter to the editor was published on January 15, 2018 and can be found here. The article in which the letter responds to can be found here. By John Rother The U.S. is alone among developed nations in failing to assure more affordable medications for its citizens. Medicare trustees have an obligation to act prudently to obtain fair prices for beneficiaries. Recent research has […]
Op-Ed: The Necessity Of Exploiting Pricing Power in a Post-Consolidated Health Care World
By John Rother & David Introcaso Originally posted on Morning Consult. You can read the original op-ed here. Americans are forced to spend over $1 trillion annually on health care services that do not improve their health. What causes this is not the amount of health care services we consume. Compared to similar countries, the […]
For Immediate Release: Statement on Texas v. U.S. Decision
Today, the National Coalition on Health Care released the following statement regarding the Federal District Court Decision in Texas v. U.S.: The highly flawed Texas court ruling threatens to increase costs for almost every American at the individual level, as no cost preventive benefits, lifetime limits and out-of-pocket limits would disappear. For taxpayers and all those who […]
Op-Ed: With a New Congress, a Window Opens to Finally Bring Down Drug Prices
You can read the original op-ed published in STAT News here. With the new Congress mostly in place, now split between a Democratic House and a Republican Senate, a new dynamic is in place. Any legislation, including efforts to rein in drug prices, will need to have bipartisan support to move forward. Bringing pricing restraint […]